Articles about Johnson & Johnson

35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab

15 Sep 2021

35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab

Around 35 lakh doses of the COVID-19 vaccine developed by United States pharma giant Johnson & Johnson have reportedly reached the apex vaccine testing laboratory in Kasauli, Himachal Pradesh.

Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October

09 Sep 2021

Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October

The one-dose COVID-19 vaccine developed by American pharma giant Johnson & Johnson and manufactured by the company's local partner, Hyderabad-based Biological E, is likely to be available in India by October, reported News18.

J&J's one-dose COVID-19 vaccine gets the nod in India

07 Aug 2021

J&J's one-dose COVID-19 vaccine gets the nod in India

India has approved Johnson & Johnson's single-dose coronavirus vaccine for emergency use, the Union Health Minister Mansukh Mandaviya announced today.

J&J applies for EUA of COVID-19 vaccine in India

06 Aug 2021

J&J applies for EUA of COVID-19 vaccine in India

Global healthcare major Johnson & Johnson on Friday said that it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India.

J&J withdraws vaccine approval request in India, CDSCO says

02 Aug 2021

J&J withdraws vaccine approval request in India, CDSCO says

Johnson & Johnson has withdrawn its proposal seeking an accelerated approval of its COVID-19 vaccine, Janssen, in India, the country's drug regulator said.

FDA adds warning of rare reaction risk to J&J vaccine

13 Jul 2021

FDA adds warning of rare reaction risk to J&J vaccine

US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction but said it's not entirely clear the shot caused the problem.

Johnson & Johnson says its vaccine works against Delta variant

02 Jul 2021

Johnson & Johnson says its vaccine works against Delta variant

Johnson & Johnson's one-shot coronavirus vaccine is effective against the highly-contagious Delta variant and provides durable protection against infection overall, the company said in a statement on Thursday.

J&J COVID-19 vaccine's expiration date extended by six weeks

11 Jun 2021

J&J COVID-19 vaccine's expiration date extended by six weeks

Johnson & Johnson said on Thursday that US regulators extended the expiration date on its COVID-19 vaccine doses by six weeks.

J&J partners with India's Biological E to produce COVID-19 vaccine

19 May 2021

J&J partners with India's Biological E to produce COVID-19 vaccine

American pharmaceutical giant Johnson & Johnson has partnered with the Indian firm Biological E. Limited for the production of its COVID-19 vaccine, a move that could boost the country's overall supplies amid a serious shortage.

US looking to produce of J&J's COVID-19 vaccine in India

12 May 2021

US looking to produce of J&J's COVID-19 vaccine in India

The United States is considering the production of Johnson & Johnson's COVID-19 vaccine in India along with ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, Charge d'Affaires of the US Embassy, said on Tuesday.

US to resume J&J COVID-19 vaccinations despite rare clot risk

24 Apr 2021

US to resume J&J COVID-19 vaccinations despite rare clot risk

US health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot, after advisers decided its benefits outweigh a rare risk of a blood clot.

US faces pressure to decide J&J COVID-19 vaccine's fate

22 Apr 2021

US faces pressure to decide J&J COVID-19 vaccine's fate

US agencies are under pressure to take a call on the resumption of the use of Johnson & Johnson's COVID-19 vaccine.

J&J seeks permission to conduct COVID-19 vaccine trial in India

20 Apr 2021

J&J seeks permission to conduct COVID-19 vaccine trial in India

US healthcare giant Johnson & Johnson said on Tuesday that it has sought approval from India's drug regulator to conduct a bridging clinical study of its single-dose COVID-19 vaccine in the country.

South Africa suspends Johnson & Johnson COVID-19 vaccine

15 Apr 2021

South Africa suspends Johnson & Johnson COVID-19 vaccine

South Africa has joined the US in suspending its roll-out of the Johnson & Johnson COVID-19 vaccine, following reports that six women who received the immunization doses had developed unusual blood clots with low platelet count.

United States recommends 'pause' on J&J vaccine after clotting concerns

13 Apr 2021

United States recommends 'pause' on J&J vaccine after clotting concerns

The United States government recommended a "pause" in the administration of the single-dose Johnson & Johnson (J&J) vaccine amid concerns of a "rare and severe type of blood clot."

J&J set to begin India trial of its single-shot vaccine

09 Apr 2021

J&J set to begin India trial of its single-shot vaccine

US pharmaceutical giant Johnson & Johnson is in talks with the Indian government to soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the company said on Friday.

15 million J&J vaccine doses ruined due to human error

01 Apr 2021

15 million J&J vaccine doses ruined due to human error

About 15 million doses of Johnson & Johnson's one-shot vaccine have been ruined after a plant in the United States mixed up ingredients, The New York Times has reported.

US FDA grants emergency use authorization for J&J's COVID-19 vaccine

28 Feb 2021

US FDA grants emergency use authorization for J&J's COVID-19 vaccine

The United States government on Saturday granted emergency approval to the COVID-19 vaccine developed by Johnson & Johnson, making it the third vaccine available to the public in the US.

Johnson & Johnson's one-shot COVID-19 vaccine highly effective: FDA

25 Feb 2021

Johnson & Johnson's one-shot COVID-19 vaccine highly effective: FDA

Johnson & Johnson's single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released by US regulators that sets the stage for a final decision on a new and easier-to-use shot.

Biological E aiming for 600 million J&J vaccine doses annually

10 Feb 2021

Biological E aiming for 600 million J&J vaccine doses annually

Hyderabad-based pharmaceutical firm Biological E Ltd. is reportedly looking to contract-manufacture 600 million annual doses of the COVID-19 vaccine developed by Johnson & Johnson.

South Africa scraps AstraZeneca vaccine, will give J&J jabs

10 Feb 2021

South Africa scraps AstraZeneca vaccine, will give J&J jabs

South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.

Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy

29 Jan 2021

Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy

Johnson & Johnson's (J&J) much-awaited COVID-19 vaccine has reportedly exhibited strong protection against the virus.

Bharat Biotech vaccine trials continued despite 'adverse event' in August

22 Nov 2020

Bharat Biotech vaccine trials continued despite 'adverse event' in August

Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.

Moderna's COVID-19 vaccine found to be 95% effective: Details here

16 Nov 2020

Moderna's COVID-19 vaccine found to be 95% effective: Details here

American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.

AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue

22 Oct 2020

AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue

A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.

Big setback: Johnson & Johnson pauses coronavirus vaccine trial

13 Oct 2020

Big setback: Johnson & Johnson pauses coronavirus vaccine trial

Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.

NewsBytes Briefing: TikTok granted injunction against US ban, and more

28 Sep 2020

NewsBytes Briefing: TikTok granted injunction against US ban, and more

Over the weekend, TikTok won a preliminary injunction against the Trump administration, which prevents the hit video service from getting banned in the US.

Johnson & Johnson's single-dose COVID-19 vaccine induces strong immunity

26 Sep 2020

Johnson & Johnson's single-dose COVID-19 vaccine induces strong immunity

Johnson & Johnson's COVID-19 vaccine has shown promise in early-to-mid-stage clinical human trials.

NewsBytes Briefing: TikTok files for injunction against ban, and more

24 Sep 2020

NewsBytes Briefing: TikTok files for injunction against ban, and more

As ByteDance's TikTok deal is likely to see more delays owing to China's pending approval, the video company is moving to prevent itself from getting banned by Trump administration.

Johnson & Johnson's COVID-19 vaccine goes into final human trials

23 Sep 2020

Johnson & Johnson's COVID-19 vaccine goes into final human trials

In a major development, American pharma giant Johnson & Johnson has launched the final trial of its COVID-19 vaccine.

COVID-19 vaccine developers to pledge against rolling out shots prematurely

06 Sep 2020

COVID-19 vaccine developers to pledge against rolling out shots prematurely

In light of the havoc wreaked by COVID-19, governments around the world have become more than willing to fast-track regulatory approvals and launch promising vaccines, anti-virals, and tests for their citizens.

NewsBytes Briefing: Fortnite removed from app stores, and more

14 Aug 2020

NewsBytes Briefing: Fortnite removed from app stores, and more

In the updates since last night, Fortnite made major headlines.

NewsBytes Briefing: Facebook, Twitter remove Trump's misleading post, and more

06 Aug 2020

NewsBytes Briefing: Facebook, Twitter remove Trump's misleading post, and more

In the updates since last night, both Facebook and Twitter launched a crackdown on a misleading post from US President Donald Trump.

As coronavirus pandemic surges, some vaccine makers expect to profit

22 Jul 2020

As coronavirus pandemic surges, some vaccine makers expect to profit

Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.

NewsBytes Briefing: Snap's revenue grows; Moderna's vaccine won't be cheap

22 Jul 2020

NewsBytes Briefing: Snap's revenue grows; Moderna's vaccine won't be cheap

The big story in the technology world is: Snap reported its earnings for Q2 2020 with notable gains - 9 million new users and 17% YoY growth in revenue.

COVID-19 vaccine: What are the latest updates?

05 Jul 2020

COVID-19 vaccine: What are the latest updates?

With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.

Skin cream "Fair & Lovely" to drop "Fair" from name

25 Jun 2020

Skin cream "Fair & Lovely" to drop "Fair" from name

Joining the bandwagon of brands that are making their products socially inclusive, the Indian unit of Unilever, Hindustan Unilever, has decided to drop "Fair" from the name of the skincare cream "Fair & Lovely," multiple reports said on Thursday.

J&J to begin human trials of COVID-19 vaccine in July

11 Jun 2020

J&J to begin human trials of COVID-19 vaccine in July

American pharma giant Johnson & Johnson has announced that it will be starting human trials of its experimental COVID-19 vaccine sooner than previously planned.

COVID-19 vaccine not guaranteed, says leading world health expert

19 Apr 2020

COVID-19 vaccine not guaranteed, says leading world health expert

With more than 160,000 deaths and 2.3 million infected cases globally, COVID-19 continues to wreak havoc around the world.

Johnson & Johnson: COVID-19's vaccine will be ready by 2021

31 Mar 2020

Johnson & Johnson: COVID-19's vaccine will be ready by 2021

American pharmaceutical giant Johnson & Johnson has announced that it has selected the lead vaccine candidate for the novel coronavirus disease COVID-19.